Skip to content
10-K/A

Annual Report

Intra-Cellular Therapies, Inc.

0001628280-25-014154

← back to feed
Filed
Mar 20, 2025 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 10, 2025 106.52M sh